HIV kliniske forsøg i Houston, TX
17 studier for HIV søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
RekruttererObservationsstudie
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
RekruttererFase 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Rekrutterer
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
RekruttererFase 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · 7 mi væk
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
RekruttererFase 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RekruttererFase 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
RekruttererFase 1Frivillige med god helbredstilstand velkomne
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Rekrutterer
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Rekrutterer
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
RekruttererFrivillige med god helbredstilstand velkomne
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
RekruttererFase 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RekruttererFase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi væk
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Rekrutterer
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
RekruttererFase 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Rekrutterer
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RekruttererFase 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RekruttererFase 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
HIV forsøg i andre byer
- Washington, DC22 studier
- New York City, NY19 studier
- Miami, FL17 studier
- Baltimore, MD16 studier
- San Francisco, CA15 studier
- Atlanta, GA14 studier
- Chicago, IL14 studier
- Boston, MA11 studier
- Philadelphia, PA11 studier
- San Diego, CA10 studier
- Los Angeles, CA9 studier
- Seattle, WA8 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.